ROS Modulation Compounds
Comprehensive analysis of 82 bioactive compounds and their effects on Reactive Oxygen Species
Compound | Dosage | Contextual Notes |
---|
Important Considerations
Reactive Oxygen Species (ROS) play complex dual roles in cellular physiology and cancer therapy:
- Dual Roles: Low physiological ROS levels support cellular signaling and proliferation, while high levels cause oxidative damage and cell death.
- Context Dependence: Effects vary significantly by cell type, metabolic state, genetic background, and microenvironment (e.g., hypoxia).
- Dosage Considerations: Many compounds shift from antioxidant to pro-oxidant effects at higher concentrations.
- Temporal Dynamics: Acute ROS increases may trigger adaptive responses while chronic elevation leads to cell death.
- Source Specificity: Compounds may target different ROS sources (mitochondria, NOX enzymes, peroxisomes) with distinct biological consequences.
This table synthesizes current research on ROS-modulating compounds. For informational and research purposes only.
ROS Fundamentals
Precise ROS Classification
ROS Name | Chemical Formula | Type | Key Biological Role/Effect |
---|---|---|---|
Hydroxyl Radical | •OH | Radical | Highly damaging to biomolecules; causes oxidative stress |
Superoxide Anion | O₂•⁻ | Radical | Mitochondrial signaling precursor; can lead to oxidative damage |
Hydrogen Peroxide | H₂O₂ | Non-Radical | Important signaling molecule; precursor to hydroxyl radicals |
Singlet Oxygen | ¹O₂ | Non-Radical | Involved in photodegradation and lipid peroxidation |
Hydroperoxyl Radical | HOO• | Radical | Involved in lipid peroxidation chain reactions |
Hypochlorite Ion | ClO⁻ | Non-Radical | Antimicrobial defense in immune cells |
Peroxynitrite | ONOO⁻ | Non-Radical | Causes nitration and oxidation of biomolecules |
Key Distinction: Radical species (•) have unpaired electrons making them highly reactive, while non-radicals like H₂O₂ require activation but can diffuse through membranes.
Dual Role of ROS in Cancer
Low/Moderate ROS
- Promotes cancer cell proliferation via MAPK/ERK pathways
- Activates pro-survival transcription factors (NF-κB, HIF-1α)
- Induces angiogenesis through VEGF signaling
High ROS
- Causes oxidative damage to DNA/proteins/lipids
- Triggers apoptosis via p53 activation
- Induces ferroptosis through lipid peroxidation
Cancer cells maintain redox reprogramming - elevated baseline ROS with enhanced antioxidant capacity (glutathione, superoxide dismutase) for survival advantage.
Advanced Therapeutic Mechanisms
Pro-Oxidant Strategies
- Antioxidant system inhibition: Targeting glutathione (buthionine sulfoximine), thioredoxin (auranofin), or superoxide dismutase
- ROS-generating agents: Artemisinin (iron-dependent), IV vitamin C (extracellular H₂O₂ generation)
- Mitochondrial targeting: Compounds like berberine that disrupt electron transport chain
ROS-Sensitive Nanomaterials
GSH-scavenging: Depletes glutathione in tumor microenvironment
H₂O₂-responsive: Drug release triggered by high peroxide levels
Fenton catalysts: Generate hydroxyl radicals at tumor site
Contextual Complexity Factors
- Genetic background: p53 status determines apoptotic response to ROS
- Microenvironment: Hypoxia stabilizes HIF-1α altering ROS responses
- Metabolic state: Glycolytic tumors vs. oxidative phosphorylation
- Temporal patterns: Acute spikes (signaling) vs. chronic elevation (damage)
No comments:
Post a Comment